Rebecca Cohen

Investor Relations Contact bij IKENA ONCOLOGY, INC.

Health Technology

Consumer Services

Actieve functies van Rebecca Cohen

Bedrijven	Functie	Begin	Einde
IKENA ONCOLOGY, INC.	Investor Relations Contact	-	-

Bedrijven	Functie	Begin	Einde
SQZ BIOTECHNOLOGIES COMPANY	Investor Relations Contact	01-01-2017	01-07-2018
SQZ BIOTECHNOLOGIES COMPANY	Public Communications Contact	01-01-2017	01-07-2018
EPIZYME, INC.	Public Communications Contact	-	01-05-2016
Jewish Big Brothers Big Sisters of Greater Boston	Directeur/Bestuurslid	-	-
Solomon Schechter Day School of Greater Boston	Directeur/Bestuurslid	-	-
MESOBLAST LIMITED	Hoofd Techniek/Wetenschap/O&O	-	-

Rutgers State University of New Jersey

Undergraduate Degree

Internationaal

Verenigde Staten	7
Australië	2

Operationeel

Public Communications Contact	2
Investor Relations Contact	2
Director/Board Member	2

Sectoraal

Health Technology	5
Consumer Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	3
SQZ BIOTECHNOLOGIES COMPANY	Health Technology
MESOBLAST LIMITED	Health Technology
IKENA ONCOLOGY, INC.	Health Technology

Bedrijven in privébezit	3
Epizyme, Inc. Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA.	Health Technology
Jewish Big Brothers Big Sisters of Greater Boston
Solomon Schechter Day School of Greater Boston